The compound provided a dose-dependent decrease in ex vivo-stimulated IL-17A levels in the blood, significantly reduced inflammation in mice collagen-induced arthritis and psoriasis models, and showed an acceptable clinical safety profile. Here, IL17A is linked to psoriasis.